Understanding risks of semaglutide peptides
Table of Contents 1. Introduction Semaglutide represents a significant advancement in the treatment of type 2 diabetes and obesity, offering a new horizon for patients struggling with these chronic conditions. As a glucagon-like peptide-1 (GLP-1) agonist, semaglutide works by mimicking an intestinal hormone that stimulates insulin release, thereby lowering blood sugar levels and facilitating weight …